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Wilms' tumor is a childhood nephroblastoma that is postulated to arise through the inactivation of a tumor suppressor gene 
by a two-hit mechanism. A candidate II p 13 Wilms' tumor gene, WT I, has been cloned and shown to encode a z:inc finger 
protein. Patients with the WAGR syndrome (Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation) have 
a high risk of developing Wilms' tumor and they carry constitutional deletions of one chromosome II allele encompassing the 
WT J gene. Analysis of the remaining WT I allele in a Wilms' tumor from a WAGR patient revealed the deletion of a single 
nucleotide in exon 7. This mutation likely played a key role in tumor formation, as it prevents translation of the DNA-bindlng 
zinc finger domain that is essential for the function of the WT I polypeptide as a transcriptional regulator. Genes Chrom Cancer 
7:131-136 (1993). © 1993 Wlley-Liss, lnc. 
INTRODUCTION 
lndividuals with the WAGR syndrome (Wilms' 
tumor, aniridia, genitourinary abnormalities, and 
mental retardation) frequently carry cytogeneti-
cally visible, constitutional deletions involving 
chromosome band llpl3 (Francke et al., 1979). 
The molecular dissection of this genomic region 
ultimately led to the isolation of the WTJ Wilms' 
tumor gene (Call et al., 1990; Gessler et al., 1990). 
The gene is transcribed into a 3 kb mRNA that can 
be differentially spliced, giving rise to four differ-
ent protein isoforms (Haber et al., 1991; Gessler et 
al., 1992). The translation product is a zinc finger 
protein that binds to DNA in a sequence specific 
manner, and it is involved in transcriptional regu-
lation (Rauscher et al., 1990; Madden et al., 1991 ). 
A small fraction of sporadic Wilms' tumors ex-
hibit homozygous deletions of this gene, some of 
them intragenic, supporting the hypothesis that 
WTJ can function as a tumor suppressor gene (Call 
et al., 1990; Gessler et al., 1990; Cowell et al., 
1991; Huff et al., 1991; Royer-Pokora et al., 1991; 
Ton et al., 1991). In most of the tumor samples 
tested, however, no deletions were found. RNA 
transcripts of this gene could still be detected in 
many cases at Ieveis comparable to those in devel-
oping kidney. This apparent discrepancy may in 
part be explained by the presence of two other loci 
(WT.:? and W13) postulated to play a role in an un-
known fraction of Wilms' tu mors (Grundy et al., 
1988; Huff et al., 1988; Koufos et al., 1989; Reeve 
et al., 1989). Alternatively, more subtle mutations 
of WTJ (Pelletieret al., 1991a) may be present in 
some cases. 
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In this report we describe the cytogenetic and 
molecular characterization of the WTJ locus in nor-
mal tissue and Wilms' tumor cells from a patient 
with WAGR syndrome. The extent of the WAGR 
deletion has beendeterminedas weil as the nature 
of the second genetic event leading to a homozy-
gous inactivation of WTJ function in tumor cells. 
MATERIALSAND METHODS 
Patient 
The patient, a boy, was born April 19, 1979, to 
healthy and normal parents. He bad bilateral anir-
idia, hypospadias, and cryptorchidism, suggesting 
the presence of the WAGR syndrome. He was 
therefore kept under observation for the develop-
ment ofWilms' tumor. At the age of almost 7 yrs he 
presented with gross hematuria, low back pain, and 
a palpable mass in the right upper abdomen. The 
tumor was removed by right radical nephrectomy 
and diagnosedas a Wilms' tumor. Follow-up at age 
12 showed no evidence of recurrent tumor in the 
patient. 
Cytogenetic Analysis 
Lymphocytes from a peripheral blood sample 
were stimulated with phytohemagglutinin and ar-
rested in early cell division with ethidium bromide 
followed by Colcemid treatment (lkeuchi, 1984). 
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Chromosomes were G-banded using trypsin treat-
ment followed by Giemsa staining (GTG-band-
ing). 
Isolation of Genomic DNA and Gene 
Dosage Analysis 
DNA from white blood cells and pulverized fro-
zen tumor tissue was isolated according to Standard 
procedures (Sambrook et al., 1989). Southern blot 
filters wich exactly 4 J.Lg of EcoRI-digested DNA 
per lane were used for hybridization in the gene 
dosage studies. Hybridization conditions and eval-
uation of gene dosage results have been described 
previously (Gessler et al., 1989). All probes used in 
this study have been characterized by Gessler et al. 
(1989, 1990). For studies on loss of heterozygosity 
at the HRAS/ and TH loci, primers and amplifica-
tion conditions were as described (Tanci et al., 
1992; Polymeropoulos et al., 1991). 
Preparation of RNA and RT -PCR Analysis 
RNA was isolated from frozen tumor tissue by 
the guanidinium-isothiocyanate/cesium chloride 
method (MacDonald et al., 1987). Single-stranded 
cDNA was prepared using the first strand kit 
(Stratagene, Heidelberg), followed by PCR ampli-
fication of the WTI fragment (nucleotides 779-
1605) as described by Gessler et al. (1992). Sub-
fragments suitable for sequencing were cloned into 
pBiuescript and sequenced using vector or internal 
cDNA primers. Sequence comparison was done us-
ing the HUSARIUWGCG sequence analysis pack-
age (DKFZ, Heidelberg). 
SSCP Analysis and Direct Sequencing of 
PCR Products 
Exon 7 DNA was amplified using primers corre-
sponding to nucleotides 156-175 and 389-408 of 
the genomic sequence at an annealing temperature 
of 60°C (X61636, Gessler et al., 1992). For SSCP 
analysis the products were Iabelied by 32P-dCTP 
incorporation and separated on non-denaturing 
polyacrylamide gels at 4°C and room temperature 
(Orita et al., 1989). 
For direct sequencing, amplification products 
were chloroform-extracted and purified by glass 
powder adsorption (Gene-clean, Bio101). DNA 
from one-tenth of a Standard amplification reaction 
was used for sequence determination using the 
fmol kit (Promega, Heidelberg) and one of the 
end-labelled PCR primers. 
RESULTS 
Clinical Findings 
Based on histology and electron microscopy, the 
Wilms' tumor (886-1334) was classified as a blast-
emal tumor with focal tubular differentiation. No 
nepbroblastomatosis was identified. Extensive 
changes were seen in the renal parenchyma, with 
interstitial fibrosis and chronic inflammation. Seg-
mental to global thickening of the mesangium and 
capillary loops was seen in a fairly diffuse fashion, 
tagether with deposits of lgM via immunofluores-
cence studies in the mesangium. 
There appears to be no impairment of inrellec-
tual functioning of the patient, as is the case for a 
fraction of WAGR patients. Although no formal IQ 
testing was done, the patient was rated as having 
average or above average intelligence by neurologic 
examiners. He does quite weil at school and at 13 
yr of age is in the seventh grade, an age-appropriate 
Ievel. 
Cytogenetic Findings 
The cytogenetic analysis from white blood cells 
revealed a male karyotype with a deletion on the 
short arm of one chromosome 11. The deletion was 
originally identified as del (ll)(p13p14.2). Reex-
amination using high resolution banding (Fig. 1) 
suggested a slightly smaller deletion, interpreted as 
del (ll)(p13p14.1 ). This is consistent with the 
presence of the W AG R syndrome in this patient. 
Molecular Characterlzation of the WAGR Deletion 
The chromosome 11 deletion was detected at 
the molecular Ievel during the screening of Wilms' 
tumor DNAs for submicroscopic deletions of the 
WT/locus wichout prior knowledge of the patient's 
phenotype. Using DNA probes covering most of 
chromosome region llp13-p14, a hemizygous de-
letion was identified in tumor DNA with the FSHB 
gene, the AN2 locus, and the WTI Wilms' tumor 
gene showing reduced gene dosage (Fig. 2). The 
flanking markers M16 and catalase (CA1) on the 
centromeric side and 74 on the telomeric side are 
present in two copies per cell. By comparison with 
the weil established physical map of this region, a 
deletion size of approximately four million base-
pairs could be deduced. 
Examinaclon of constitutional DNA from white 
blood cells of the patient showed the same hemi-
zygous deletion. In DNA from the patient's fa-
eher, however, no reduction of gene dosage for any 
of the markers resred could be found. There was 
no DNA available from the mother. Given the ab-
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Figure I. Partial karyotypes and idiogram of chromosome I I, illus-
trating the normal (N) and the deletion of material from bands II p 13 
and llpl-4.1 (A). 
sence of clinical signs like aniridia in both parents, 
it is likely that the deletion detected in the patient 
represents a new mutation. 
Analysis of the Remaining WTI Allele in 
TumorDNA 
The presence of a constitutional deletion of one 
WTJ aUele suggested that inactivation of the sec-
ond WTJ allele may have caused tumor formation 
in this case. By Southern blot analysis~ no evidence 
for alteration in any of the genomic DNA frag-
ments of the remaining WTI allele could be found. 
Nonhern blot analysis with RNA from tumor tissue 
revealed the presence of a normal size transcript for 
WTJ (data not shown), leaving the possibility that 
a more subtle mutation might interfere with the 
expression of a functional protein product. 
We therefore examined the coding region of the 
WTJ mRNA by sequence analysis. A fragment cor-
responding to nucleotides 779-1605 of the WTJ 
sequence was amplified from reverse transcribed 
tumor RNA and subcloned. Sequence analysis of 
the entire fragment revealed the presence of a sin-
gle mutation in exon 7 of the WTJ gene (Fig. 3). 
The deletion of nucleotide 1284 Ieads to a transla-
tional frameshift resulting in a premature termina-
tion of ehe reading frame. In this case~ the protein 
product would likely be nonfunctional as it is de-
void of the essential zinc finger domain which me-
diates DNA binding. The mutation has been con-
firmed on several independent cDNA clones as 
weU as by direct sequencing of exon 7 ampJified 
from tumor DNA (not shown). 
The mutant genomic exon, amplified from tu-
mor DNA, produces a variant banding pattern 
upon SSCP analysis. In constitutional DNA from 
this patient, however, only the normal DNA frag-
ments are seen. Thus, the deletion of one nucle-
otide from the remaining aJJele of ehe WTJ gene is 
a tumor-specific event. 
To assess a possible loss of heterozygosicy at 
chromosome band 1 lp15 (i.e., the W12 locus), we 
analyzed polymorphic repeat sequences at the 
HRASJ and TH loci (Tanci et al., 1992; PoJymero-
poulos et aJ., 1991). For both loci, tumor DNA was 
heterozygous, thus ruling out loss of a larger ge-
nomic segment during tumor formation. 
DISCUSSION 
The patient described in this study developed 
Wilms' tumor rather late, at the age of 83 months. 
The medianage at presentation for the subgroup of 
cases that are associated wich hypospadia and crypt-
orchidism is 21.5 months (Breslow et al., 1988). 
These genitourinary malformations are likely 
caused by the absence of one WTJ alleJe in consti-
tmional DNA of our patient, since mutations at the 
WTJ gene can exert a dominant effect on ehe de-
velopment of the urogenital system (Pelletier et 
al., 1991a). 
Similarly, bilateral aniridia is presumably due to 
the reduction in gene dosage for the entire ANZ 
locus as tested by probe 495. InterestingJy, the 
patient shows apparently normal mental develop-
ment. Approximately cwo-thirds ofWAGR patients 
wich cytogenetic deletions are mentally retarded 
(Russen and Weisskopf, 1986), but a putative locus 
for this component of the WAGR syndrome has not 
yet been mapped. The )arge size of the deletion in 
our patient implies that such a gene may be located 
at a significant distance from the other two W AG R 
genes, WTJ and ANl, which are found wiehin less 
than one million basepairs (Compton et aJ., 1988; 
Gessler and Bruns, 1989). 
The WAG R-associated deletion spans a consid-
erable genomic distance and must include a large 
number of other genes. This would likely prevent 
inactivation of ehe second WTJ copy by chromo-
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flgure 2. Gene closage analysls of DNA from Wilms' tumor S86-
13:W. Southem blot filters prepared wlth exactly 4 ""' of fcoRI digested 
normal human control DNA (lanes C, 6697 cells. Gessler et al., 1989) 
and 586-1334 tumor DNA (586) were hybridixed sequentially with the 
probes listed. for probes p257T, pLKI (WTI), and p202. an approxi-
mately SO% reduction of the hybridization signal compared to control 
some loss or mitotic recombination which is fre-
quently detected as loss of heterozygosity (LOH) 
in other tumors. There are several reponed cases of 
Wilms' rumors with two independent, large dele-
tions on both chromosome 11 alleles (Ca II et al., 
1990; Gessler et al., 1990; Royer-Pokora et al., 
1991; Ton et al., 1991). The resulting region of ho-
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DNA was seen. Probe 495 marks the AN2 aniridia locus, which is in· 
cluded in the deletion. The schematic diagram depicu the location o( all 
probes used within the consensus physical map that has been established 
by pulsed field gel analysis (Compton et al., 1988; Gessler and Bruns, 
1989). 
mozygous deletion, however, was always limited to 
a few hundred kilobase pairs around the WTJJocus. 
The second event in our case was the deletion in 
the WTJ coding region of a single nucleotide, de-
tected in DNA and RNA from the patient's tumor. 
The mutation changes the translational reading 
frame. The altered transcript encodes a polypep-
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5 1 •• AGGA~GTGCGAGTGTGCCTGGAGTAGCCCC •• 3 1 
•• AspV.a IArgVal.CX:i.J!ilY.Y.lY.!.!~ WTS86 
+ 5 I •• .AGGATGTGCGACGTGTGCCTGGAGTA'GCCCC. • 3 ' Normal .• AspValArgArgValProGlyValAla •. 
Fipe 3. Sequence analysis of the WT I transcript from Wllms' tumor 586-1334. Deletion of a single 
nudeotide (C) is seen. The shift in readlng frame Ieads to four altered amino acld residues followed by a 
premature stop codon. The truncated proteln ls missing the zJnc flnger domaln encoded in exons 7 to 10. 
tide lacking rhe essential DNA-binding domain of 
four consecutive zinc fingers. This would likely 
prevent its normal functioning and Iead to a com-
plete loss of WTJ activiry, consistent wich the two 
hit model for Wilms' tumor development (Knud-
son and Strang, 1973 ). Similar small deletions or 
point mutacions of WTJ in Wilms' tumors have 
been described recently in non-WAGR patients 
(Pelletieret al., 1991a; Little et al., 1992). In all 
cases, the region encoding the zinc fingers is al-
tered or preceded by stop codons. 
Henry et al. (1989) could demonstrate loss of 
heterozygosity limited to the llp15 region-the lo-
cation of the postulated WT2 gene-in Wilms' tu-
mor DNA from a WAGR deletion patient, suggest-
ing that both loci, WTJ and W12, may be affected 
in the same tumor. lt is interesting to note that, in 
our case loci at chromosome band llp15 remained 
heterozygous in tumor DNA. This does not rule 
out, however, that other alterations at llplS have 
occurred during tumor formation. 
Microscopical examination of the kidney adja-
cent to the tumor showed features that are com-
patible with a broader definition of Denys-Drash 
syndrome (Eddy and Mauer, 1985). Recently, Pel-
letieret al. (1991b) have reported a striking corre-
lation between this syndrome and highly specific 
point mutations altering a single amino acid of the 
WTJ zinc finger domain, which exert a strong dom-
inant effect on kidney development. These data 
suggest that the kidney changes seen in our case 
may be based on mechanisms different from those 
acting in Denys-Drash syndrome. 
The homozygous inactivation of the WTJ gene 
in this tumorfurther supports the postulated role of 
this gene as a tumor suppressor gene and provides 
a direct explanation for the high frequency of 
Wilms' tumor formation in individuals with 
WAGR-associated deletions. 
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